TrialPloS one2011

Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.

Beryl A Koblin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.